相关实验视频

Updated: Jul 11, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.0K

重新评估雌激素受体表达值,以预测 HER2 阴性患者的乳腺癌,使用形状受限建模

Wenli Dong1, Takeo Fujii2, Jing Ning1

  • 1University of Texas MD Anderson Cancer Center Division of Quantitative Sciences.

Research square
|November 14, 2023
PubMed
概括

10%的雌激素受体 (ER) 表达切断预测乳腺癌的复发. ER<10%的患者可能无法从内分泌疗法中受益,这有助于治疗决策.

关键词:
内分泌疗法是一种内分泌疗法.雌激素受体的受体是什么建模模型 建模模型幸存的生存方式这是一个值.

更多相关视频

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:29

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

162

相关概念视频